Hemoglobinopathies are divided into two main groups: thalassemia syndromes with quantitative defects leading to reduced levels of one type of globin chain, and structural Hb variants, such as SCD, with qualitative defects causing a change in the structure of the Hb molecule. This evidence concerns the gene GSTM1 and Schnyder corneal dystrophy.